India's Pharmaceutical Exports

Country Profile

Papua New Guinea

Papua New Guinea is an emerging destination for Indian pharmaceutical exports — $20.3M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 80% of shipments, with vaccines contributing $2.51M. The compound annual growth rate since FY2016 stands at 6.7%.

🇵🇬 $20.3M · 1.9× growth since FY2016 · 6.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$20.3M
Exports FY2025–26 DGCIS
1.9×
Growth FY2016→2026
6.7%
CAGR FY2016→2026
80%
Medicines Share
4
Product Categories Supplied
Papua New Guinea is an emerging destination for Indian pharmaceutical exports — $20.3M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 80% of shipments, with vaccines contributing $2.51M. The compound annual growth rate since FY2016 stands at 6.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $16.3M (80.4%) Vaccines $2.51M (12.4%) Surgical & Hospital Supplies $1.38M (6.8%) Traditional & Herbal $95K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Papua New Guinea in the RBI overseas direct investment dataset (2011–2026).